These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2007-000236-16||A Double-Blind, Randomized, Placebo- and Active Comparator- Controlled, Parallel Group, Multinational Study to Evaluate the Pharmacokinetics and Pharmacodynamics of IPX056 in Subjects with Established...||2008-05-06||due-trials|
|Reported results||2009-010193-38||A Placebo-Controlled Study to Evaluate the Safety and Efficacy of IPX066 in Subjects with Parkinson's Disease||2010-09-28||due-trials|
|Listed as ongoing, but also has a completion date and reported results||2009-014688-37||A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson’s Disease||2011-01-19||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2009-017182-38||An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects with Parkinson’s Disease.||2011-10-21||bad-data|
|Listed as ongoing, but also has a completion date and reported results||2009-017238-39||A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066 in Advanced Parkinson’s Disease||2012-01-12||bad-data|
|Ongoing||2018-002233-37||A randomized controlled study to compare the safety and efficacy of IPX203 with immediate-release carbidopa-levodopa in Parkinson's disease patients with motor fluctuations.||not-yet-due|
|Ongoing||2018-002234-21||AN OPEN-LABEL EXTENSION STUDY OF THE SAFETY AND CLINICAL UTILITY OF IPX203 IN PARKINSON’S DISEASE PATIENTS WITH MOTOR FLUCTUATIONS||not-yet-due|